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Abstract
IFNg is critical for host defence against various food-borne pathogens including Salmonella enterica
and Listeria monocytogenes, the causative agents of salmonellosis and listeriosis, respectively. We
investigated the impact of regional IFNg expression at the intestinal epithelial barrier on host invasion
by salmonellae and listeriae following oral challenge. Transgenic mice (IFNg-gut), generated on an
IFNg knock-out (KO) background, selectively expressed IFNg in the gut driven by the modified liver
fatty acid-binding protein (Fabpl43 at 2132) promoter. Infections with attenuated S. enterica
Typhimurium or with L. monocytogenes did not differ significantly in IFNg-KO, IFNg-gut and wild-type
mice. Further, Listeria-specific CD41 and CD81 T cells were not altered in IFNg-gut mice. Thus, this
model indicates that local IFNg expression by non-immunological cells in the distal part of the small
intestine, caecum and colon is insufficient for prevention of gut penetration by S. enterica
Typhimurium and L. monocytogenes.
Introduction
Salmonella enterica and Listeria monocytogenes are intra-
cellular bacterial pathogens, which enter the host through
the gut epithelial barrier during natural infection (1, 2).
Hence, the intestinal epithelium provides a first line of de-
fence against these food-borne pathogens. Once these
pathogens have successfully penetrated the epithelium, they
rapidly spread to other tissue sites. Following oral infection,
salmonellae replicate in mucosa-associated lymphoid tis-
sues such as the Peyer’s patches (PP) and subsequently
disseminate via the mesenteric lymph nodes (MLNs) (3). Lis-
teriae and salmonellae, in addition to invading the host via
PP in the small intestine and disseminating via MLN, can en-
ter through the colon (4) or via CD18-expressing phagocytes
(5), respectively. Listeriae that enter through the colon
subsequently spread via the caudal lymph node (CLN)
(4, 6). Innate immune defence against infectious agents is
mediated by various cytokines, which interact in a
highly regulated network (7, 8). The importance of IFNc in in-
testinal host defence against S. enterica Typhimurium and
L. monocytogenes has been extensively documented (3, 9–16).
This is true both for systemic and regional defence. Previous
studies identified elevated levels of IFNc mRNA in gut-
associated lymphoid tissue after challenge with S. enterica
Typhimurium (15). In PP, IFNc mRNA was detected at 6 h, in
MLN at 24 h and in spleen at 4 days after challenge. Admin-
istration of neutralizing mAbs to IFNc completely abrogates
resistance to oral challenge with salmonellae and listeriae
(9, 15) and susceptibility to systemic infection is greatly en-
hanced (17). IFNc is produced by both activated T cells and
NK cells during host defence against these pathogens
(7, 16). In addition, impaired host intestinal immunity in
IFNc-deficient mice following S. enterica Typhimurium or L.
monocytogenes oral challenge has been demonstrated
(3, 18, 19).
We generated IFNc transgenic mice, which exclusively
produce IFNc in the gut on a general IFNc knock-out (KO)
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background (IFNc-gut) to directly examine the role of re-
gional IFNc production in the intestinal epithelium against
the intracellular pathogens S. enterica Typhimurium and
L. monocytogenes. The expression of IFNc is driven by the
modified liver fatty acid-binding protein (Fabpl43 at 132) pro-
moter that exhibits gut-specific expression with increasing
activity from the proximal to the distal part of the small intes-
tine as well as in the caecum and colon (20). A low level of
expression in the kidney was also reported (20). The IFNc-
gut mice were orally infected with S. enterica Typhimurium,
strain SL7207, which is deficient in aroA or with L. monocyto-
genes strain EGD, and penetration of the intestinal epithelial
barrier by these pathogens was analysed. Moreover, we
characterized T cell responses in the different mouse strains
following infection with L. monocytogenes. Our experiments
reveal that despite similar pathogen-specific CD4+ and
CD8+ T cell responses in IFNc-gut mice, regional IFNc ex-
pression by epithelial cells is insufficient for efficacious con-
trol of infection.
Methods
Generation of IFNc-gut mice
The Fabpl43 at 132 promoter was cleaved from a recombi-
nant plasmid (kind gift from J. Gordon, St Louis, Missouri,
USA) using EcoRI and BamHI restriction enzymes. A 469-
bp IFNc cDNA fragment was PCR amplified from a recombi-
nant plasmid containing the full-length IFNc cDNA with
oligonucleotides containing BamHI and XbaI restriction sites.
The 5#-end primer was 5#-CGGGATCCATGAACGCTACA-
CACTGCATC-3# and the 3#-end primer was 5#-GCTCTAGAT-
CAGCAGCGACTCCTTTTCCGC-3#. The resulting PCR
product was cleaved with BamHI and XbaI at the 5#- and
3#-ends, respectively. The SV40 small t-intron/polyadenyla-
tion sequence was PCR amplified from the vector pGL2-
Basic (Promega, Madison, WI, USA) with oligonucleotides
containing restriction sites that enabled the resulting product
to be cleaved with XbaI and NotI at the 5#- and 3#-ends, re-
spectively. The Fabpl43 at 132 promoter, the IFNc cDNA
and the SV40 small t-intron/polyadenylation sequence were
cloned into pBluescript in that order. Transient transfections
using lipofectin (Invitrogen, Carlsbad, CA, USA) with this
recombinant plasmid into 293T cells were performed accord-
ing to the manufacturer’s protocol and supernatants re-
moved and concentrated 4-fold using AMICON (10 000 kDa
cut-off) spin columns. IFNc in supernatants was detected by
ELISA using mAb R4-6A2 to capture the IFNc and mAb
XMG1.2 biotin labelled followed by streptavidin conjugated
with peroxidase to detect the captured IFNc. To generate
the IFNc-gut mice, the complete construct was cleaved out
of the vector with EcoRI and NotI, gel purified and used for
pro-nuclear injection of oocytes from an IFNc-KO mouse on
a C57Bl/6 background (kind gift from T. Stewart, South San
Francisco, CA, USA).
RNA isolation and quantitative PCR
Mice were sacrificed before or after Salmonella or Listeria in-
fection (see below). RNA from tissue samples (2 cm intesti-
nal sections and ;50 mg from other organs) was isolated
with TRIzol (Invitrogen) using the FastRNA tubes green
(Q-Biogene, Irvine, CA, USA) and subjected to DNAse I
treatment according to their protocol. Quantity and quality of
isolated RNA were determined by the Bioanalyser and by
OD measurement. Reverse transcription was performed with
random primers using the Superscript reverse transcription
kit from Invitrogen. Quantitative PCR was performed with
SyBR Green mix (Applied Biosystems, Foster City, CA, USA)
using the Applied Biosystems machine. The real-time PCR
mixture was prepared as follows: 15 ll SyBR Green mix,
0.15 ll of a 100 pm solution each of forward and reverse
primer and 5 ll of a 1:15 diluted cDNA synthesized accord-
ing to the reverse transcription kit. Each sample for real-time
PCR was made in triplicate and mean of the resulting three
values were taken. The following primers for IFNc, IFNc-
inducible protein-10 (IP10) and IFN-inducible GTPase (IIGP)
amplifications were used: IFNc forward 5#-ACGGCACAGT-
CATTGAAAGCCTA-3# and reverse 5#-GTCACCATCCTTTT-
GCCAGTTCC-3#, IP10 forward 5#-CCGTCATTTTCTGCCTC-
ATCCT-3# and reverse 5#-GCTTCCCTATGGCCCTCATTCT-3#
and IIGP forward 5#-GCCACCAATCTTCCTGCTCTCTAAC-3#
and reverse 5#-CTTCCAGCCAAATCCTCTGCTTC-3#.
Histology
Macroscopic and microscopic examination of histopathology
(inflammation) was performed in situ and in formalin-fixed
intestinal tissue, respectively. Microscopical analysis was
performed in a blind fashion for signs of infiltration, ulcera-
tion, mucosal thickening, haemorrhage and epithelial cell
integrity.
Oral infections with salmonellae and listeriae
A frozen aliquot of deficient (aroA–) S. enterica Typhimurium
(SL7207) or wild-type (wt) S. enterica Typhimurium (SL1344)
was inoculated in 100 ml of Luria–Bertani (LB) medium con-
taining 0.3 M NaCl and left overnight in a 37C incubator.
A frozen aliquot of L. monocytogenes strain EGD was inocu-
lated in 100 ml tryptic soy broth and incubated at 37C over-
night with gentle shaking at 90 r.p.m. Bacterial cultures were
harvested by centrifugation at 3000 3 g for 10 min in 50 ml
Falcon tubes and washed twice in PBS. After OD600 mea-
surement, they were diluted with PBS from 0.5 3 109 to
1.5 3 1010 colony-forming units (CFU) per ml (taking OD600
as 109 CFU) and 200 ll was used for intragastric gavage.
CFU were always controlled by plating of serial dilutions of
the inoculum. To determine bacterial burdens, mice were
sacrificed after 1 or 2 days, spleen and MLNs homogenized
in PBS and serial dilutions of homogenates were plated on
LB agar plates. Colonies were counted after overnight incu-
bation at 37C.
Purification of cells and intracellular cytokine staining
Lymphocytes from spleen, MLNs, small intestine epithelium
and small intestine lamina propria were isolated as previ-
ously described (21, 22). Cells (1 3 106–4 3 106) were cul-
tured in a 1-ml volume of RPMI 1640 medium supplemented
with glutamine, Na-pyruvate, b-mercaptoethanol, penicillin,
streptomycin and 10% heat-inactivated FCS. Cells were
stimulated for 5 h with 106 M of the peptides listeriolysin O
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amino acids 190–201 (LLO190–201, NEKYAQAYPNVS) or oval-
bumin257–264 (OVA257–264, SIINFEKL). During the final 4 h of
culture, 10 lg ml1 brefeldin A (Sigma Aldrich, Taufkirchen,
Germany) was added. Cultured cells were washed and
incubated for 10 min with rat serum and anti-CD16/CD32
mAb to block non-specific antibody binding. Subsequently,
cells were either stained with PE-conjugated anti-CD4 mAb
or PE–Cy7-conjugated anti-CD8a mAb, and after 30 min on
ice, cells were washed with PBS and fixed for 20 min at
room temperature with PBS 4% PFA. Cells were washed with
PBS and 0.1% BSA, permeabilized with PBS, 0.1% BSA and
0.5% saponin (Sigma) and incubated in this buffer with
rat serum and anti-CD16/CD32 mAb. After 5 min, Cy5-
conjugated anti-tumour necrosis factor a (TNFa) mAb was
added. After a further 20 min at room temperature, cells
were washed with PBS and fixed with PBS 1% PFA. Cells
were analysed using a FACS Canto and DIVA software
(Becton-Dickinson, Mountain View, CA, USA).
Antibodies
Anti-CD16/CD32 mAb (clone: 2.4G2) and anti-TNFa mAb
(XT22) were purified from rat serum or hybridoma supernatants
with protein G sepharose. Antibodies were Cy5-conjugated
according to the standard protocols. PE-conjugated anti-
CD4 mAb (GK1.5) and PE–Cy7-conjugated anti-CD8a mAb
(53-6.7) were purchased from BD PharMingen (San Diego,
CA, USA).
Infection of mice for determination of T cell responses
C57Bl/6 mice were bred in our facility and experiments
were conducted according to the German animal protection
laws. All mice were infected with a recombinant Listeria
monocytogenes strain-expressing ovalbumin (23), termed
LmOVA. Mice were infected with 2 3 109 LmOVA by gastric
incubation and were analysed on day 9 post-infection (p.i.).
Results
IFNc expression driven by the modified Fabpl promoter,
Fabpl43 at 132
The transgenic construct contained mouse IFNc cDNA
downstream of the Fabpl43 at 132 promoter. To avoid any
endogenous post-transcriptional regulatory sequences in
the IFNc mRNA, the cloned 469-bp IFNc cDNA contained
only the sequence from the AUG start codon to the UGA
stop codon. 293T kidney cells were transfected with the
transgenic construct and production of IFNc was deter-
mined. In the supernatant of transfected 293T kidney cells,
but not of control cells, IFNc was detected by ELISA (data
not shown) indicating that the construct was functional.
Gut-specific and functional IFNc expression in transgenic
mice
The IFNc-gut mice were generated on an IFNc-KO back-
ground. In IFNc-gut mice, the IFNc cDNA signal was
detected and mice were deficient for the endogenous IFNc
gene as determined by the PCR on DNA isolated from tail
clips (data not shown). Compared with wt mice, the trans-
genic mice expressed IFNc in the distal part of the small in-
testine at levels similar to wt mice and expression increased
towards the caecum with a maximum level of expression in
the colon. Quantitative PCR analysis (Table 1) revealed that
IFNc expression was elevated 19-fold in the caecum and
44-fold in the colon relative to IFNc expression levels in wt
mice. We analysed RNA levels of the IFNc-responsive genes
IP10 and IIGP to verify whether the transgene-encoded IFNc
was functionally active. Compared with wt mice, IP10 mRNA
expression in IFNc-gut mice was 2.5-fold and 5.3-fold higher
in caecum and colon, respectively. IIGP RNA was 8-fold
and 13-fold higher in IFNc-gut caecum and colon, respec-
tively (Table 1). There was an increase in IFNc expression
levels in wt caecum and colon, 48 h p.i. with S. enterica
Typhimurium aroA, as the IFNc levels in both caecum and
colon in IFNc-gut mice were only ;9- and 8-fold higher, re-
spectively, compared with wt mice (Table 1). Levels of IFNc-
responsive genes, IP10 and IIGP, were also up-regulated.
IP10 levels were higher in caecum and colon of infected wt
mice; in IFNc-gut mice, levels were only 1.25-fold and
+1.15-fold different while they were 2.54-fold and 5.35-fold
higher when compared with naive wt mice. (A negative value
such as 1.25-fold in IFNc-gut mice versus infected wt mice
indicates it is 1.25-fold greater in infected wt compared with
IFNc-gut mice.) Similarly, IIGP levels were only 3.6-fold and
2.3-fold higher in caecum and colon of IFNc-gut mice com-
pared with infected wt mice while these were 8-fold and 13-
fold higher when compared with naive wt mice. As
Table 1. Expression levels of IFNc, IP10 and IIGP in the small intestine, caecum and colon of IFNc-gut mice relative to wt mice as
estimated by quantitative PCRa
Comparison of IFNc-gut
mice versus
Gene
product
Expression level (fold difference) in
Small intestine
(proximal region)
Small intestine
(distal region)
Caecum Colon
wt-naive mice IFNc 35.75 + 0.30 1.89 + 0.30 19.20 + 0.22 44.94 + 0.21
wt-infected mice IFNc 13.96 + 0.18 1.54 + 0.17 8.92 + 0.32 7.98 + 0.18
wt-naive mice IP10 2.89 + 0.20 1.66 + 0.24 2.54 + 0.25 5.35 + 0.22
wt-infected mice IP10 1.90 + 0.13 4.32 + 0.14 1.25 + 0.05 1.15 + 0.15
wt-naive mice IIGP 6.45 + 0.26 1.19 + 0.16 8.09 + 0.14 13.24 + 0.27
wt-infected mice IIGP 7.93 + 0.57 4.53 + 0.12 3.61 + 0.22 2.30 + 0.11
aData are expressed as means + SD in IFNc-gut mice relative to naive or infected (48 h after oral infections with Salmonella enterica Typhimurium
aroA) wt mice. A negative value describes a lower response (lower mRNA level of IFNc, IP10 or IIGP) in IFNc-gut compared with wt mice.
A positive value describes a higher response (higher mRNA level of IFNc, IP10 or IIGP) in IFNc-gut compared with wt mice.
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expected, we did not observe any differences in IFNc mes-
sage levels between infected and naive IFNc-gut mice as
the Fabpl43 at 132 promoter is not up-regulated upon infec-
tion (data not shown).
ELISA on systemic compartments such as the MLNs, liver
and spleen did not reveal the presence of IFNc protein (data
not shown). Similarly, we did not detect any IFNc in systemic
compartments or in serum of IFNc-gut mice on western blots
with antibodies against IFNc although they did bind to
recombinant IFNc that was used as a positive control (data
not shown).
Histological examination of the gut
IFNc-gut mice did not show any signs of infiltration, ulcera-
tion, mucosal thickening, haemorrhage or epithelial cell in-
tegrity (data not shown). Therefore, compared with the wt
mice, IFNc-gut mice were free of apparent signs of pathol-
ogy indicating that the levels of IFNc produced regionally in
the IFNc-gut mice did not lead to chronic inflammation.
Oral infection with attenuated S. enterica Typhimurium
IFNc-gut, IFNc-KO and wt mice were orally infected with the
wt, fully virulent S. enterica Typhimurium strain SL1344 (Fig. 1A)
and CFU in spleen and MLN were determined. Using this
strain, we observed similar CFU in MLNs and spleens of
IFNc-KO and IFNc-gut mice. Once past the intestinal barrier,
S. enterica Typhimurium rapidly multiplies, especially in the
absence of IFNc, making it difficult to determine any major
difference in the CFU between wt, IFNc-KO and IFNc-gut
mice. Therefore, mice were orally infected with the attenu-
ated aroA S. enterica Typhimurium strain SL7207, which
shows reduced growth in vivo. Figure 1(B) demonstrates
that after SL7207 infection, the range of CFU in MLNs and
spleens of IFNc-gut mice was similar to that in IFNc-KO
mice, as well. Thus, regional IFNc expression in the distal
part of the small intestine, caecum and colon was insufficient
to control penetration of the gut epithelial barrier by salmo-
nellae through uptake by PP, at least at the IFNc abundance
produced by IFNc-gut mice.
Fig. 1. Bacterial load in MLN and spleen 48 h after infections of wt, IFNc-gut and IFNc-KO mice. (A) Five mice per group were intragastrically
infected with 1 3 108 wt Salmonella enterica Typhimurium SL1344. This experiment was repeated twice with similar results. (B) Seven mice per
group were intragastrically infected with 1.8 3 109 S. enterica Typhimurium aroA strain. The experiment was repeated three times with similar
results. (C) Bacterial load in MLN and spleen 24 h after intragastric infections of wt, IFNc-gut and IFNc-KO mice. Ten mice per group were
infected with 3.0 3 109 Listeria monocytogenes EGD strain. This experiment was repeated twice with similar results.
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Oral infection with L. monocytogenes
IFNc-gut, IFNc-KO and wt mice were orally infected with
L. monocytogenes, and CFU in MLN and spleen were deter-
mined (Fig. 1C). Similar to S. enterica Typhimurium infection,
listerial CFU in the MLN did not show significant differences
among the three groups although CFU in MLN of wt mice
were lower than those in IFNc-KO mice. Hardly any CFU
were detected in spleen suggesting the absence of signifi-
cant injury during intragastric gavage. As with spleens, we
observed increased CFU in the liver after 48 h (data not
shown). This was probably due to invasion and multiplication
of bacteria rather than due to injury during intragastric
gavage since in the latter case we would have already
observed increased CFU after 24 h. Since the colon
of IFNc-gut mice expressed 44-fold more IFNc compared
with wt mice, and as the colon is drained through the CLN,
CFU in CLN were determined after oral infection with
L. monocytogenes. No significant differences were observed
among the different groups of mice (data not shown). This
may also be due to a narrow temporal window before lister-
iae invade the CLN.
Antigen-specific T cell responses in intestinal tissues
To determine whether local IFNc expression in the gut
affects antigen-specific CD4+ and CD8+ T cell responses,
IFNc-gut, IFNc-KO and wt mice were orally infected with 2 3
109 CFU LmOVA. Bacteria were cleared by antibiotics at
day 3 p.i. and LLO190–201-specific CD4
+ and OVA257–264-
specific CD8+ T cell responses were measured at day 9 p.i.
in spleen, MLN and in the intraepithelial lymphocytes and
LPL compartment (21, 22). Since IFNc secretion by T cells
could not be used for determination of specific T cells in
IFNc mutant mice, TNFa secretion was measured. Three in-
dependent experiments similarly demonstrated that the local
expression of IFNc affected neither LLO190–201-specific CD4
+
nor OVA257–264-specific CD8
+ T cell responses (Fig. 2). In
contrast to wt mice, OVA-specific T cell responses were
slightly increased in IFNc-gut and in IFNc-KO mice. This
could be explained by the increased antigenic load in INFc-
gut mice due to initially elevated bacterial titres or by the
regulatory function of IFNc, as recently described (24).
Discussion
The data presented suggest that exclusive IFNc production
in the gut is insufficient for control of penetration of the gut
epithelial barrier by food-borne bacterial pathogens such as
S. enterica Typhimurium and L. monocytogenes. Host inva-
sion by listeriae after oral infection proceeds via the gastro-
intestinal tract (4). Because colon and rectum are drained
by CLN (4), dissemination and subsequent systemic infec-
tion involve CLN. Penetration of the small intestine involves
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Fig. 2. Specific CD4+ and CD8+ T cell responses in intestinal tissues
following infection of mice with Listeria monocytogenes. wt, IFNc-KO
(KO) and IFNc-gut (tg) mice were intragastrically infected with 2.0 3
109 LmOVA. Nine days p.i., mice were killed and lymphocytes were
isolated from spleen (A), MLNs (B), the lamina propria (C) and the
epithelium (D) of the small intestine. Cells were incubated for 5 h
without peptide or with the peptides LLO190–201 or OVA257–264 to
stimulate listeriolysin-specific CD4+ T cells or OVA-specific CD8+
T cells, respectively. Following incubation, cells were stained
extracellularly with anti-CD4 mAb or anti-CD8a mAb and intracellu-
larly with anti-TNFa mAb and analysed by flow cytometry. Bars in
figures show frequencies of TNFa-secreting cells among CD4+ (left
column) or CD8+ Tcells (right column) following incubation with (black
bars) and without peptide (white bars). Bars represent mean 6 SD of
three individually analysed mice. The experiment shown is represen-
tative of three independent experiments, each with three individually
analysed mice per mouse strain.
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uptake by PP from where listeriae spread via the lymph to
the spleen and liver. Salmonellae, on the other hand, pene-
trate the gut epithelial barrier mainly through the PP in the
small intestine. General failure to produce IFNc increases
susceptibility of mice to bacterial infection (3). Thus, evi-
dence has been presented that IFNc produced in the intes-
tine plays a role in regional host defence against food-borne
bacterial pathogens (3, 15). In this study, we aimed at deter-
mining the impact of gut-specific IFNc expression on re-
gional host defence against food-borne bacterial infection.
To achieve this goal, we created IFNc-gut transgenic mice
on an IFNc-KO background, selectively expressing IFNc in
the small intestine, caecum and colon.
The IFNc-gut mice expressed an increasing gradient of
IFNc from the distal region of the small intestine to the colon
(see Table 1). In the distal part of the small intestine, the
amount of IFNc mRNA was comparable to naive wt controls
and towards the proximal region it was lower than in wt
mice. IFNc-gut caecum and colon had 19-fold and 44-fold
more IFNc mRNA, respectively, relative to wt mice. These
levels are not reached during an oral infection of wt mice
with S. enterica Typhimurium aroA. This became apparent
when comparing caecum and colon of IFNc-gut mice rela-
tive to infected wt mice, where the levels of IFNc-gut were
only 9-fold to 8-fold higher. The IFNc-responsive genes,
IP10 and IIGP, also followed this pattern in the caecum
and colon, i.e. higher IFNc expression resulted in more IP10
and IIGP mRNA expression, demonstrating that the IFNc ex-
pressed in IFNc-gut mice was functional. In addition, minute
expression was found in the kidney but none in liver and stom-
ach (data not shown) as expected from the Fabpl43 at 132
promoter expression pattern. This promoter was reported to
drive expression in goblet, enteroendocrine, and Paneth
cells throughout the duodenal-ileal axis and in colon that
lacks Paneth cells (20).
Our data reveal that regional IFNc production in the intes-
tine (at least at the moderate levels in the small intestine with
an increasing gradient towards the colon, produced in the
IFNc-gut mice described here) is insufficient for control of the
spread of salmonellae and listeriae from the gut to the MLN.
Because salmonellae penetrate the gut epithelial barrier
mainly through uptake by PP, this gradient of IFNc expression
may explain the lower Salmonella burden in MLN of IFNc-gut
mice as compared with IFNc-KO mice and higher Salmonella
burden compared with wt mice. We assume that in the proxi-
mal part of the small intestine, little or virtually no IFNc is pro-
duced to activate antibacterial capacities in macrophages. In
this region, salmonellae can penetrate the epithelium through
PP. Towards the distal region of the small intestine, IFNc ex-
pression increased and could partly contribute to control of
the salmonellae resulting in lower CFU in MLN. Although in
IFNc-gut mice IFNc was not expressed in PP, we cannot ex-
clude that IFNc may have diffused into the PP and stimulated
immune cells. However, in contrast to the extent of control of
salmonellae seen in wt mice, lack of sufficient control of sal-
monellae in IFNc-gut mice suggests that the amount of IFNc
produced by gut epithelial cells that may have entered the
PP was too low to compensate for lack of IFNc production
by immune cells in PP. Another possibility is that the immune
response mounted against salmonellae in the distal part of
the small intestine in IFNc-gut mice was more efficacious due
to IFNc expression whereas in the proximal part and in the
other parts of the small intestine, immunity was weak or ab-
sent. This could explain apparent lack of an effective immune
response in MLN of IFNc-gut mice. Thus, in spite of local
IFNc expression, no significant differences were observed
between IFNc-gut and IFNc-KO mice in host defence against
oral Salmonella and Listeria infections, although after oral
Salmonella infection the CFU in MLN of IFNc-gut mice were
lower than those in IFNc-KO mice. As expected, wt mice
showed lower CFU in MLN compared with IFNc-KO mice
when infected with either salmonellae or listeriae.
It could be argued that the IFNc concentration in IFNc-gut
mice was below the required threshold levels for macro-
phage activation. However, real-time PCR data suggest that
the lowest levels of IFNc that were detected in the distal part
of the small intestine in IFNc-gut mice were similar to IFNc
concentrations measured in naive wt mice and increased up
to 44-fold, relative to wt mice, in the colon. Yet, CFU in
IFNc-gut mice were consistently higher than those in the
caecum and colon of wt mice. Given that regional IFNc ex-
pression in the gut was sufficient for control at the gut bar-
rier, the CFU in MLN of IFNc-gut mice should have been
significantly less than CFU in MLN of IFNc-KO mice, at least
with listeriae, which can penetrate the gut epithelial barrier
through PP-independent mechanisms.
There is some controversy as to which immune cells pro-
duce IFNc during bacterial infection. NK cells, T cells, DCs
and macrophages are thought to be major producers of
IFNc although it has been reported that IFNc produced by
macrophages and DCs rather than by NK cells and T cells
primarily contributes to control of listerial infections, after
intra-peritoneal administration (16). In any case, our results
imply that immune cells, rather than gut epithelial cells,
represent the crucial source of IFNc in defence against
food-borne bacterial infections
Because NK cells, T cells, DCs and macrophages in IFNc-
gut mice do not produce IFNc (due to the general IFNc defi-
ciency), we assume that IFNc production by these immune
cells is essential for effective antibacterial defence against
salmonellae and listeriae at the gut barrier in normal mice.
In these mice, IFNc produced by NK cells and T cells during
infection probably stimulates additional IFNc secretion in
antigen-presenting cells namely macrophages and DCs (16).
This could ultimately cause efficient activation of antibacte-
rial capacities in macrophages. This feedback loop is inter-
rupted in IFNc-gut and IFNc-KO mice because of general
IFNc deficiency. It has to be noted that LLO190–201-specific
CD4+ and OVA257–264-specific CD8
+ T cell functions were
not impaired in both mutant mouse strains. In contrast, as
a consequence of the reduced anti-microbial capacity of
IFNc mutant mice, the increased antigenic load in these
mice may explain slightly enhanced frequencies of antigen-
specific CD4+ and CD8+ T cells as compared with wt mice.
In conclusion, our experiments suggest that regional IFNc
expression by non-immunological cells at the gut barrier is
insufficient for regional defence against food-borne infection
with S. enterica and L. monocytogenes. On the other hand,
in wt mice, IFNc clearly plays a central role in the defence
against these pathogens and it is possible that increasing
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the amount of regional IFNc expression in the gut improves
control of bacterial infections at the gut barrier. Such consti-
tutively produced high IFNc levels, however, could favour
the development of chronic inflammation (25).
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Abbreviations
CFU colony-forming units
CLN caudal lymph node
Fabpl liver fatty acid-binding protein
IIGP IFN-inducible GTPase
IP10 IFNc-inducible protein-10
KO knock-out
LB Luria–Bertani
LLO190–201 listeriolysin O amino acids 190–201
LmOVA Listeria monocytogenes strain-expressing ovalbumin
MLN mesenteric lymph node
OVA257–264 ovalbumin257–264
p.i. post-infection
PP Peyer’s patches
TNFa tumour necrosis factor a
wt wild type
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